Introduction {#s1}
============

During the cell cycle one of the key processes following DNA replication is the re-assembly of chromatin on the newly replicated DNA. This involves the re-deposition of both pre-existing and newly synthesised histones into intact nucleosomes (reviewed in [@bib13]; [@bib33]; [@bib14]). This process must be tightly controlled and in *S. cerevisiae* one key event is the Rtt109-mediated modification of histone H3 by acetylation of lysine 56 (H3K56) ([@bib16]; [@bib12]). Rtt109 cooperates with two different histone chaperones Asf1 and Vps75 ([@bib37]; [@bib12]) and although it is generally accepted that Asf1 is the major chaperone involved in promoting H3K56 acetylation ([@bib21]; [@bib36]), recent evidence suggests a role for Vps75 in this process ([@bib32]). However, the signalling pathways controlling Rtt109-mediated H3K56 acetylation are unknown. Another important modification that occurs coincidentally with DNA replication is H3 phosphorylation at threonine T45 (H3T45) but current evidence suggests that this modification has no relationship with the closely located H3K56 acetylation event ([@bib3]). In the context of an unperturbed cell cycle, Cdc7-Dbf4 has been shown to be a major kinase involved in controlling H3T45 phosphorylation levels ([@bib3]).

*S. cerevisiae* possesses one protein kinase C isoform, Pkc1, and it is known to play a major role in cell wall integrity signalling (reviewed in [@bib24]). Pkc1 has a growing number of nuclear functions and through genetic experiments this protein kinase has previously been implicated in cell cycle events (reviewed in [@bib24]). Part of this role can be attributed to its connection to pathways sensing cell wall integrity and its effects on the activity of the downstream MAP kinase pathway. However MAP kinase-independent roles for Pkc1 have emerged and Pkc1 was recently shown to directly affect the cell cycle by inhibiting the activity of the transcriptional coactivator protein Ndd1 ([@bib9]). This finding suggested that Pkc1p might act as a checkpoint kinase under conditions of replicative stress where progression to G2 phase is inhibited. However, mutant strains containing *ndd1* mutant alleles lacking the Pkc1 phosphorylation sites did not fully re-capitulate the *pkc1* mutant phenotypes, indicating that additional defects are associated with loss of Pkc1 activity. Indeed, *pkc1* mutants are sensitive to hydroxurea (HU) treatment ([@bib31]), suggesting a potential role for Pkc1 in controlling the response to replicative stress. It is unclear how Pkc1 might affect replicative stress but previous genetic studies have linked *PKC1* and components of the RSC chromatin remodelling complex and Pkc1 overexpression can suppress the defects associated with *RSC* mutants ([@bib5]; [@bib17]; reviewed in [@bib24]). This is suggestive of a potential role for Pkc1 in regulating chromatin assembly during DNA replication.

Here, we have investigated the potential role of Pkc1 in controlling chromatin modifications during replicative stress and found that it coordinates the deposition of two histone marks on histone H3, T45 phosphorylation and K56 acetylation. Mechanistically, Pkc1 controls H3K56 acetylation through phosphorylation-dependent activation of Rtt109. Moreover, Pkc1 also promotes H3T45 phosphorylation and this modification is important for the coordinated deposition of H3K56 acetylation.

Results {#s2}
=======

Pkc1 is required for cell viability and chromatin integrity under replicative stress conditions {#s2-1}
-----------------------------------------------------------------------------------------------

To examine whether Pkc1 has a role in protecting cells from replicative stress we first determined cell sensitivity to hydroxyurea (HU) in the presence and absence of active Pkc1. To do this we made use of strains containing temperature sensitive *pkc1* alleles which could be inactivated by incubating yeast cells at 34ºC, thereby negating the confounding effects of heat shock stress response obtained using the traditionally used *pkc1^ts ^*allele ([@bib2]). In comparison to cells containing wild-type *PKC1* (DK186), temperature sensitive *pkc1-14* (DK1690) cells, grown at 34ºC to inactivate Pkc1 were inviable ([Figure 1A](#fig1){ref-type="fig"}, top panel) consistent with previous studies using a *pkc1*Δ deletion strain ([@bib31]). Loss of *PKC1* function results in cell lysis in the absence of osmotic support. The presence of sorbitol saved the *pkc1-14* mutant phenotype ([Figure 1A](#fig1){ref-type="fig"}, middle panel) but HU sensitivity was observed under these conditions ([Figure 1A](#fig1){ref-type="fig"}, bottom panel). This suggested a role for Pkc1 other than signalling through the well studied downstream MAP kinase cascade which includes the kinase Bck1 ([@bib22]). Indeed *bck1*Δ (Y01328) cells were not sensitive to HU, further emphasising a new alternative mechanism of action for Pkc1 under replicative stress conditions ([Figure 1A](#fig1){ref-type="fig"}). To determine whether the kinase activity of Pkc1 is needed to protect cells from replicative stress, we attempted to rescue *pkc1-14* cells by re-expressing a catalytically dead (KD) version of Pkc1 in the presence of HU. However, while wild-type (WT) Pkc1 was able to rescue the growth defect of *pkc1-14* cells, the catalytically dead version was unable to do so ([Figure 1B](#fig1){ref-type="fig"}).10.7554/eLife.09886.003Figure 1.Pkc1p is required for cell viability and chromatin integrity in the presence of hydroxyurea.(**A** and **B**) Cell growth assays. (**A**) 10 fold serial dilutions of wild-type (WT) (DK186), *pkc1-14* (DK1690) or *bck1Δ* (Y01328) cells were plated onto YPD media in the presence or absence of 1M sorbitol or (**B**) *pkc1-14* (DK1690) cells containing empty vector or plasmids expressing WT or kinase dead (KD) Pkc1, were plated onto SD media in the presence 1M sorbitol. Cells were grown at 34ºC and where indicated, 100 mM HU was added to the media.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.003](10.7554/eLife.09886.003)

Together, these experiments demonstrate that Pkc1 kinase activity is required for protecting cells from replicative stress.

Pkc1 is required for H3K56 acetylation {#s2-2}
--------------------------------------

During S phase, acetylation of histone H3 at lysine 56 (H3K56) is an important modification in ensuring the correct assembly of newly synthesised nucleosomes and their incorporation into chromatin ([@bib25]; [@bib26]). We therefore examined whether Pkc1 is required for H3K56 acetylation under replicative stress conditions. Upon release from a HU block, wild-type cells showed accumulation of acetylated H3K56 ([Figure 2A](#fig2){ref-type="fig"}, lanes 1--6). In contrast, temperature sensitive *pkc1-21* cells (DK1697) showed much reduced levels of H3K56 acetylation when grown at 34ºC ([Figure 2A](#fig2){ref-type="fig"}, lanes 7--12) even though they had progressed through S phase and arrested at G2 ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Importantly, this effect was not limited to strains harbouring the *pkc1-21* allele but was also observed in a different temperature sensitive strain, harbouring the *pkc1-14* allele either upon release from a HU block ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) or upon entry into S phase upon release from an α factor block ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). H3K56 acetylation is deposited by Rtt109, and this enzyme also acetylates histone H3 at lysine 9 (H3K9) ([@bib12]; [@bib16]; [@bib37]). Interestingly, in addition to H3K56 acetylation defects, *pkc1-14* cells showed much reduced levels of H3K9 acetylation ([Figure 2B](#fig2){ref-type="fig"}, middle panel) which suggests a defect in Rtt109 activity.10.7554/eLife.09886.004Figure 2.Pkc1p controls H3K56 acetylation.(**A-C**) Western blot analysis of the H3K56 acetylation levels in (**A**) WT (DK186) or *pkc1-21* (DK1697) or (**B**) WT (DK186) or *pkc1-14* (DK1690) strains grown in YPD in the presence 1M sorbitol at 34ºC, treated with 200 mM HU for 2.5 hrs and released into YPD with sorbitol for the indicated times. (**C**) WT (DK186) cells grown in the presence or absence of cercosporamide at 30ºC in YPD, exposed to 200 mM HU for 2.5 hrs and released from a HU block for the indicated times. H3K9 acetylation levels are also shown in (**B**) and Histone H3 and tubulin (Tub1) are shown as loading controls.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.004](10.7554/eLife.09886.004)10.7554/eLife.09886.005Figure 2---figure supplement 1.The *pkc1-21* and *pkc1-14* mutants exhibit a mitotic delay.Cells from strains containing wild-type (WT) *PKC1* (DK186) and the temperature sensitive *pkc1-21* (DK1697) and *pkc1-14* (DK1690) mutants were grown to early log phase at 30ºC in YPD supplemented with 1 M sorbitol, blocked with 200 mM HU for 2.5 hrs at 34ºC, washed and released into a fresh YPD media containing sorbitol at 34ºC. Aliquots were taken at the indicated times, analysed for propidium iodine staining by FACS, and the DNA content histograms were determined for at least 30,000 cells. The location of peaks corresponding to haploid (1n) and diploid (2n) DNA content are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.005](10.7554/eLife.09886.005)10.7554/eLife.09886.006Figure 2---figure supplement 2.The role of Pkc1 in controlling H3K56 acetylation.Western blot analysis of the H3K56 acetylation levels in WT (DK186) or *pkc1-14* (DK1690) strains. Cells were released alpha factor block for the indicated times. Histone H3 and tubulin (Tub1) are shown as loading controls. All experiments were performed at 34ºC in YPD plus sorbitol.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.006](10.7554/eLife.09886.006)10.7554/eLife.09886.007Figure 2---figure supplement 3.Comparison of genetic and pharmacological disruption of Pkc1 activity on H3K56 acetylation.(**A**) Western blot analysis of the H3K56 acetylation levels in WT (DK186)(top) or *pkc1-14* (DK1690)(bottom) strains. Cells were grown in the presence or absence of cercosporamide at 34ºC in YPD plus 1M sorbitol and were released from a 200 mM HU block for the indicated times. Histone H3 and tubulin (Tub1) are shown as loading controls. (**B**) Quantification of the H3K56ac levels in (**A**) normalised for tubulin and total H3 levels and shown relative to the WT cells prior to release from HU block (taken as "1"; indicated by dashed line).**DOI:** [http://dx.doi.org/10.7554/eLife.09886.007](10.7554/eLife.09886.007)

To further explore the role of Pkc1 in promoting H3K56 acetylation, we treated wild-type cells with the Pkc1 inhibitor cercosporamide ([@bib35]) and examined H3K56 acetylation following release from a HU block. Pharmacological inhibition of Pkc1 activity reduced H3K56 acetylation but importantly did not affect another histone H3 acetylation event at lysine 18 (H3K18) ([Figure 2C](#fig2){ref-type="fig"}), demonstrating the specificity of action of Pkc1. We also examined whether combinatorial genetic inactivation and pharmacological inhibition of Pkc1 has additive effects but none were observed, indicating that the effect of cercosporamide was through Pkc1 ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). We note however that the loss of Pkc1 in the temperature sensitive strains resulted in stronger reductions in H3K56ac levels than following cercosporamide treatment, most likely due to incomplete Pkc1 inhibition in the latter case.

Together these results demonstrate an important role for Pkc1 in promoting H3K56 acetylation under replicative stress conditions.

Pkc1 mediates Rtt109 phosphorylation {#s2-3}
------------------------------------

The reduced levels of H3K9 and H3K56 acetylation observed upon disruption of Pkc1 activity suggested that the acetyltransferase Rtt109 which deposits these modifications might be targeted by Pkc1. One mechanism might be through Pkc1-mediated control of Rtt109 phosphorylation. Inspection of Rtt109 sequence revealed a potential phosphorylation site at threonine 46 (T46) which partially matches the PKC consensus sequence ([Figure 3A](#fig3){ref-type="fig"}). To establish whether Rtt109 can be phosphorylated by Pkc1 at this site, we raised a phospho-specific antibody which specifically recognised a phosphorylated peptide surrounding T46 ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). In vitro kinase assays revealed that Pkc1 was able to phosphorylate Rtt109 in the context of a purified recombinant Rtt109-Vps75 heterodimer ([Figure 3B](#fig3){ref-type="fig"}). This phosphorylation was reduced to background levels following treatment with lambda phosphatase ([Figure 3B](#fig3){ref-type="fig"}, lane 3). Immunoprecipitation assays demonstrated that Pkc1 and Rtt109 could interact in vitro ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).10.7554/eLife.09886.008Figure 3.Pkc1-mediated Rtt109 phosphorylation.(**A**) Location and local sequence contexts of the potential Pkc1p target site in Rtt109 (numbers indicate amino acid positions in the protein). (**B**) In vitro kinase assay using HA epitope-tagged Pkc1p immunoprecipitated from DZ2 cells and purified recombinant Rtt109-Vps75 protein complex. A HA IP from wild-type yeast cells was used as a control. Where indicated, λ phosphatase was added. Rtt109, HA-Pkc1 and phosphorylated Rtt109 T46 (phospho-Rtt109) were detected by immunoblotting (IB). (**C** and **D**) Rtt109 T46 phosphorylation *in vivo*. DZ5 cells were grown in SD media at 30ºC, treated with 200 mM HU for the indicated times and either (**C**) released from the HU block for the indicated times or (**D**) treated with or without cercosporamide. Rtt109 and phosphorylated Rtt109 T46 were detected by IB. Quantification of Rtt109 phosphorylation from (**C**) relative to total Rtt109 levels is shown on the right.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.008](10.7554/eLife.09886.008)10.7554/eLife.09886.009Figure 3---figure supplement 1.Pkc1 and Rtt109 phosphorylation.(**A**) A phospho-specific antibody specifically recognises a phosphorylated peptide surrounding T46. A modified (phosphorylation at T46; phospho-Rtt109) DDKRVPKST(P)IKTC or non-modified peptide (Rtt109) DDKRVPKSTIKTC were dotted in increasing concentrations (2, 5, 10 µg) onto Hybond-C nitrocellulose membranes and immunoblotting was carried out with 1:1000 dilutions of antibodies to the phosphorylated or non-phosphorylated form of Rtt109. (**B**) Pkc1 interacts with Rtt109 in vitro. Immunoprecipitation assay of in vitro translated Rtt109 with anti-HA antibody bound to HA-tagged Pkc1 immunoprecipitated from DZ2 strain or with an anti-HA antibody mock immunoprecipitate from a wild-type strain lacking HA-tagged Pkc1 as a negative control.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.009](10.7554/eLife.09886.009)

Rtt109 phosphorylation at T46 could also be identified *in vivo* following HU treatment ([Figure 3C](#fig3){ref-type="fig"}, lanes 1--4). This phosphorylation was subsequently lost upon release from HU arrest ([Figure 3C](#fig3){ref-type="fig"}, lanes 5--6). Importantly, treatment of cells with cercosporamide prior to HU addition blocked the appearance of Rtt109 phosphorylation at T46 ([Figure 3D](#fig3){ref-type="fig"}), demonstrating a role for Pkc1 in promoting Rtt109 phosphorylation under replicative stress conditions.

These data therefore indicate that in cells undergoing replicative stress, Rtt109 is phosphorylated in a Pkc1-dependent manner, most likely through direct phosphorylation by Pkc1.

Phosphorylation of Rtt109 is important for H3K56 acetylation {#s2-4}
------------------------------------------------------------

To establish whether phosphorylation of Rtt109 at T46 has any functional relevance, we attempted to rescue *rtt109*Δ cells lacking Rtt109 protein expression with plasmids encoding mutant proteins which had either lost the ability to be phosphorylated (T46A) or carried a phosphomimetic residue in place of T45 (T46D). In the presence of HU, *rtt109*Δ cells grew poorly ([Figure 4A](#fig4){ref-type="fig"}). This growth defect could be rescued by re-expressing wild-type Rtt109 but this rescue was lost with the non-phosphorylatable Rtt109(T46A) mutant. In contrast, Rtt109(T46D) was able to suppress the growth defect ([Figure 4A](#fig4){ref-type="fig"}) indicating that the insertion of a phosphomimetic residue at the Pkc1 phosphorylation site reinstated the activity of Rtt109. To understand the molecular basis to this rescue, we again examined H3K56 acetylation. As expected, this was severely depleted in *rtt109*Δ cells but restored upon re-expression of wild-type Rtt109 ([Figure 4B](#fig4){ref-type="fig"}, left panels). Rtt109(T46A) only partially re-constituted H3K56 acetylation levels and the kinetics were delayed whereas Rtt109(T46D) promoted rapid and high levels of H3K56 acetylation ([Figure 4B](#fig4){ref-type="fig"}, left panels). These results are fully consistent with a role for Pkc1-mediated phosphorylation of Rtt109 being required for its ability to promote H3K56 acetylation.10.7554/eLife.09886.010Figure 4.Rtt109 phosphorylation is needed for efficient H3K56 acetylation.(**A**) Cell growth assays. 10 fold serial dilutions of *rtt109Δ* (Y01490) cells containing plasmids expressing WT or the indicated Rtt109 mutants, were plated onto SD media in the presence or absence of 100 mM HU. (**B**) Western blot analysis of the H3K56 acetylation (ac) levels in *rtt109Δ* cells containing empty vector (DZ8) or plasmids expressing WT or the indicated Rtt109 mutants (DZ5-7) grown in SD media at 30ºC and released from a 200 mM HU block for the indicated times. Total Rtt109 and Histone H3 levels are also shown. (**C**) Western blot analysis of Rtt109 levels in (WT) (DK186) or *pkc1-14* (DK1690) cells containing empty vector (con) or a plasmid containing Myc-tagged Rtt109, grown in SD media in the presence of 1 M sorbitol at 34ºC and released from a 200 mM HU block for the indicated times.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.010](10.7554/eLife.09886.010)10.7554/eLife.09886.011Figure 4---figure supplement 1.*RTT109* expression is elevated in *pkc1-14* cells.RT-PCR analysis of *RTT109* and *HTT2* (control) expression in wild-type (WT)(DK186) (grey lines) or *pkc1-14* (DK1690) (black lines) cells released from 200 mM HU block for the indicated times in YPD plus sorbitol at 34ºC. Data are shown relative to *18S rRNA* levels.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.011](10.7554/eLife.09886.011)

Interestingly, we found that while wild-type Rtt109 and Rtt109(T46D) were inducibly expressed to high levels upon release from HU arrest, Rtt109(T46A) expression was delayed and reached a lower level ([Figure 4B](#fig4){ref-type="fig"}, right hand panels). This suggested that Pkc1-mediated phosphorylation might be important for stabilising Rtt109. Indeed, we found that Rtt109 protein was expressed to lower levels in *pkc1-14* cells ([Figure 4C](#fig4){ref-type="fig"}). This was not due to a transcriptional defect as *RTT109* mRNA levels were elevated in *pkc1-14* cells ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), suggesting that these cells are attempting to compensate for the loss in Rtt109 protein. This lower level of Rtt109 likely contributes to the decreased levels of H3K56 acetylation we observed. Together, these results indicated that Pkc1-mediated Rtt109 phosphorylation is required for maintaining Rtt109 protein levels and H3K56 acetylation levels as cells recover from HU-mediated replicative stress.

One prediction from these results is that any chromatin changes should manifest themselves in similar gene expression profiles when *pkc1-14* cells or cells expressing Rtt109(T46A) are compared. Indeed, in cells released from HU block, a highly significant overlap was observed for *pkc1-14* cells or cells expressing Rtt109(T46A) in genes either downregulated or upregulated compared to wild-type cells ([Figure 5A and B](#fig5){ref-type="fig"}). Importantly no such significant overlaps were observed when we considered genes that were regulated in opposite directions in the two mutant strains ([Figure 5B](#fig5){ref-type="fig"}). Furthermore, when we considered the biological processes that were affected, there was a strong overlap in gene ontology (GO) terms, with over-representation of GO terms associated with processes such as \'cell wall\' and \'nucleolus\' strongly associated with both mutant strains and reciprocal effects seen with \'telomere maintenance\' and \'DNA helicase activity\' ([Figure 5C and D](#fig5){ref-type="fig"}). These data therefore further support a strong association between Pkc1 activity, phosphorylation of Rtt109 at T46 and subsequent downstream effects on chromatin structure and gene expression. One prediction of these results is that the phosphomimetic version of Rtt109 might be able to bypass the defects seen in *pkc1-14* cells. However, no rescue of the growth defects of *pkc1-14* cells in the presence of HU was observed ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Therefore a working model suggested a direct role for Pkc1 in controlling H3K56 acetylation through Rtt109 phosphorylation but also that additional activities were controlled by Pkc1 ([Figure 5E](#fig5){ref-type="fig"}).10.7554/eLife.09886.012Figure 5.*Pkc1* and *RTT109* phosphorylation mutants generate overlapping gene expression defects.(**A**) Venn diagrams showing the overlap of significantly upregulated (top) or downregulated (bottom) genes in *pkc1-14* (DK1690) or *rtt109(T46A)* (DZ6) cells released from a 200 mM HU block. The experiment was performed by growing all strains in SD media supplemented with 1M sorbitol at 34ºC. (**B**) Prevalence of gene expression changes showing the indicated directionality of change (shown as a percentage of genes changed in the *rtt109(T46A)* mutant strain). Hypergeometric P-values are shown (NS = non-significant). (**C**) Boxplots (left) and heatmaps (right) showing the rank orders of significantly changing GO terms associated with genes whose expression is consistently changed in the *pkc1-14* (DK1690) (left) or *rtt109(T46A)* (DZ6) (right) cells. The GO terms are ranked according to changes in the *rtt109(T46A)* (DZ6) mutant. In the heat maps, the columns indicate the P-value ranking of GO terms associated with genes that consistently increase (left) or decrease (right) their expression in the respective mutant strain. (**D**) Heat map showing the relative expression of the genes contained in the \'Nucleolus\' and \'DNA helicase\' categories across all conditions analysed. DK186 and DZ5 are the WT equivalent strains for the *pkc1-14* (DK1690) and *rtt109(T46A)* (DZ6) mutant strains. Brackets indicate genes that are consistently up- or down-regulated in both mutant strains upon release from a HU block. (**E**) Model for Pkc1 function through phosphorylating Rtt109 and promoting its ability to acetylate (Ac) histone H3 K56. Question mark indicates additional activities of Pkc1.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.012](10.7554/eLife.09886.012)10.7554/eLife.09886.013Figure 5---figure supplement 1.Rescue of the HU sensitivity of *pkc1-14* by a *rtt109* phosphomimetic allele.10-fold serial dilutions of wild-type (WT; DK186), *pkc1-14* (DK1690) containing empty vector pCM188 or pAS4106 (expressing Rtt109\[T46D\]) were spotted onto SD plates in the presence of sorbitol with or without 100 mM HU and incubated at 34°C for 3 days.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.013](10.7554/eLife.09886.013)

Pkc1 mediates histone H3 T45 phosphorylation {#s2-5}
--------------------------------------------

Previous results in mammalian cells had shown that PKCδ phosphorylates histone H3 at threonine 45 (H3T45) ([@bib18]). As this residue is conserved in *S. cerevisiae* ([Figure 6A](#fig6){ref-type="fig"}), and is located in the vicinity of K56, it is possible that Pkc1-mediated phosphorylation of T45 might influence acetylation events at K56. We therefore examined whether Pkc1 could phosphorylate H3T45 in vitro by using purified histone H3 and immunoprecipitated Pkc1p. Efficient H3 phosphorylation was observed ([Figure 6B](#fig6){ref-type="fig"}) and phosphorylation at T45 was confirmed as the only major phosphorylation site by mass spectrometry ([Figure 6C](#fig6){ref-type="fig"}). Next we examined H3T45 phosphorylation and its dependence on Pkc1 *in vivo*. As cells were released from a HU-mediated block, H3T45 became strongly phosphorylated in wild-type cells ([Figure 6D](#fig6){ref-type="fig"}). However, no such rises in H3T45 phosphorylation were observed upon ablation of Pkc1 activity in *pkc1-14* cells ([Figure 6D](#fig6){ref-type="fig"}, lanes 7--12).10.7554/eLife.09886.014Figure 6.Pkc1 promotes histone H3 T45 phosphorylation.(**A**) Location and local sequence contexts of the Pkc1p target site in histone H3 (numbers indicate amino acid positions in the protein and human H3 is shown below). (**B**) In vitro kinase assay using HA epitope-tagged Pkc1p immunoprecipitated from DZ2 cells and recombinant histone H3 or GST as substrates. Protein phosphorylation was visualised by phosphorimaging (right panel) and total input proteins by Coomassie blue staining (left panel). (**C**) Product ion spectra for the doubly-charged precursor ion \[556.78\]^2+^. The spectra is fully annotated, and includes both b- and y-ions that support phosphorylation (**p**) at the residue indicated, Thr45. (**D**) Histone H3 T45 phosphorylation *in vivo*. WT (DK186) or *pkc1-14* (DK1690) cells were grown in SD media in the presence of 1M sorbitol at 34ºC and were treated with 200 mM HU and released from the HU block for the indicated times. Histone H3 and phosphorylated H3 T45 (H3T45-P) were detected by IB.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.014](10.7554/eLife.09886.014)

The results therefore indicate that Pkc1 mediates histone H3 phosphorylation under conditions of replicative stress.

Pkc1-mediated histone H3 T45 phosphorylation promotes H3 K56 acetylation {#s2-6}
------------------------------------------------------------------------

Given the relatively close proximity of T45 to K56 in the histone H3 tail and the link of modifications of both of these residues to Pkc1 activity, we next asked whether there is a connection between H3T45 phosphorylation and H3K56 acetylation. Importantly, H3K56 acetylation was greatly reduced in cells containing the H3(T45A) allele upon release from a HU block ([Figure 7A](#fig7){ref-type="fig"}, lanes 3 and 4; [Figure 7B](#fig7){ref-type="fig"}). In contrast only a small change in H3K56 acetylation was observed upon release from an alpha factor block under normal growth conditions ([Figure 7A](#fig7){ref-type="fig"}, lanes 1 and 2). However, if cells were released from an alpha factor-mediated G1 arrest into HU, and the HU subsequently removed, H3K56 acetylation again accumulated following HU removal in wild-type cells. This accumulation of H3K56 acetylation did not occur in cells harbouring the *H3(T45A)* mutant allele ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These results suggested functional coupling between H3T45 phosphorylation and H3K56 acetylation. To further probe this phenomenon, we asked whether the Rtt109(T46D) mutant could bypass the defects seen in cells containing the *H3(T45A)* mutant allele. However, only low levels of H3K56 acetylation were observed in the presence of Rtt109(T46D) ([Figure 7C](#fig7){ref-type="fig"}), demonstrating that this protein was unable to suppress the defects from H3(T45A) thereby indicating a crucial role for H3T45 phosphorylation in promoting H3K56 acetylation. Indeed, the Rtt109(T46D) mutant couldn't bypass the growth defects of *H3(T45A)* cells in HU ([Figure 7D](#fig7){ref-type="fig"}). We also tested whether Rtt109(D) could bypass the HU-mediated growth defects of *H3(K56R)* cells but again this mutant was unable to rescue the growth defect ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). This further emphasises the importance of Rtt109-mediated H3K56 acetylation in protecting against the deleterious effects of HU treatment, even when H3T45 was available for phosphorylation. These results lead to a model whereby Pkc1 signals through promoting phosphorylation of both Rtt109 and histone H3 to promote H3K56 acetylation. One prediction from this model is that downstream gene expression defects should be at least partially shared by *pkc1-14, H3(T45A)* and *Rtt109(T46A)* mutant strains. Indeed pairwise comparisons of the gene expression changes observed between these strains following release from a HU block, showed highly significant overlaps in genes being upregulated in all cases ([Figure 7E](#fig7){ref-type="fig"}; [Figure 5B](#fig5){ref-type="fig"}). Importantly though, of the 51 genes showing significant upregulation in the *pkc1* and *Rtt109(T46A)* mutant strains, 41 (80%) were also upregulated in the *H3(T45A)* mutant strain ([Figure 7E](#fig7){ref-type="fig"}). Moreover, consistent co-regulation of genes in the \'DNA helicase\' GO term category could be observed across all mutant strains ([Figure 7F](#fig7){ref-type="fig"}). These mutants therefore exhibit common defects in gene expression. This finding provides further supporting evidence that adds to the mechanistic links we have uncovered between Pkc1, Rtt109, H3T45 phosphorylation and H3K56 acetylation, and strengthens our major discovery that Pkc1 coordinates histone H3 modifications during the replicative stress response.10.7554/eLife.09886.015Figure 7.Phosphorylation of histone H3 T45 is required for efficient H3 K56 acetylation.(**A** and **B**) Western blot analysis of K56 acetylation (H3K56Ac) and total H3 levels in (MSY748) cells containing plasmids expressing H3(WT) or the H3(T45A) mutant following release from an alpha factor or HU block for the indicated times. Cells were grown in SD media at 30ºC and treated with either alpha factor for 3 hrs or 200 mM HU for 2.5 hrs prior to release. Tubulin (Tub1) levels are shown as a loading control. Logarithmically growing (FXY19) cells containing a plasmid expressing the H3(K56R) mutant are shown as a control in (**A**). (**C**) Western blot analysis of T45 phosphorylation (H3T45-P), K56 acetylation (H3K56Ac), K18 (H3K18Ac) and total H3 levels in cells containing plasmids expressing H3(WT) (MSY748) or the H3(T45A) (H3-T45A) mutant following release from a HU block for the indicated times. Where indicated cells also expressed Rtt109(T46D). (**D**) Cell growth assays. 10 fold serial dilutions of cells containing plasmids expressing H3(WT) (MSY748) or the H3(T45A) (H3-T45A) plus either Rtt109(WT) or Rtt109(T46D), were plated onto SD media in the presence (bottom panel) or absence (top panel) of 100 mM HU. (**E**) Frequency of gene expression changes upregulated in the *H3(T45A)* mutant strain that are also upregulated in either the *rtt109(T46A)* or the *pkc1-14* cells or in both of these mutant strains. Hypergeometric P-values are shown (NS = non-significant). (**F**) Heat map showing the relative expression of the genes contained in the \'DNA helicase\' category across all conditions analysed. DK186, DZ5 and MSY748 are the WT equivalent strains for the *pkc1-14* (DK1690), *rtt109(T46A)* (DZ6) and *H3(T46A)* mutant strains respectively. The experiment was performed by growing all strains in SD media supplemented with 1M sorbitol at 34ºC. Brackets indicate genes that are generally down-regulated in all of the mutant strains upon release from a HU block. (**G**) Model for Pkc1 function through phosphorylating Rtt109 and promoting its ability to acetylate (Ac) histone H3 K56 and acting through mediating H3 T45 phosphorylation which in turn enhances K56 acetylation.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.015](10.7554/eLife.09886.015)10.7554/eLife.09886.016Figure 7---figure supplement 1.H3K56 acetylation is lost in the *H3(T45A)* mutant strain upon release from an alpha factor block.Western blot analysis of H3K56 and H3K18 acetylation levels in MSY748 cells expressing wild-type H3(WT) or mutant H3(T45A). Cells were synchronised in G1 with a-factor and released into YPD media containing 200 mM HU for 90 min. Cells were then washed and released into fresh YPD media lacking HU for the indicated times and analysed by western blotting. Histone H3 and tubulin (Tub1) are shown as loading controls.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.016](10.7554/eLife.09886.016)10.7554/eLife.09886.017Figure 7---figure supplement 2.Cell growth assays of strains containing histone H3 mutants in the presence of phospho-mimetic versions of Rtt109.10 fold serial dilutions of cells containing plasmids expressing H3(WT) (MSY748), H3(T45A) (H3-T45A) or H3(T45A) plus Rtt109(T46D) (top three rows), H3(WT) (RMY200), H3(K56R) (FXY19) or H3(K56R) plus Rtt109(T46D) (top three rows), were plated onto SD media containing 1 M sorbitol in the presence (bottom panel) or absence (top panel) of 100 mM HU.**DOI:** [http://dx.doi.org/10.7554/eLife.09886.017](10.7554/eLife.09886.017)

Discussion {#s3}
==========

Newly synthesised DNA must be efficiently packaged into chromatin to ensure that genome stability is maintained (reviewed in [@bib13]; [@bib33]; [@bib14]). This must be achieved during both an unperturbed cell cycle and under conditions of replicative stress where the cell cycle must pause to ensure DNA repair occurs before recommencing the cycle. Histone H3 T45 phosphorylation and K56 acetylation are two important modifications that occur during S phase and are required for chromatin reassembly ([@bib26]; [@bib19]; [@bib29]; [@bib25]; [@bib3]). Here we show that in *S. cerevisiae* Pkc1 coordinates the deposition of these two marks under conditions of replicative stress. Previous results had implicated the Cdc7/Dbf4 kinase complex in directly controlling H3T45 phosphorylation during S phase of and unperturbed cell cycle but this kinase did not affect H3K56 acetylation ([@bib3]). However, a role under replicative stress conditions was not investigated and residual levels of H3T45 phosphorylation were observed in the *cdc7*Δ cells, indicating the existence of another H3T45 kinase. Indeed, Cdc7/Dbf4 activity has been shown to be downregulated under conditions of replicative stress, suggesting the involvement of a different histone H3 kinase under these conditions ([@bib41]). Here we focussed on histone H3 modification control under replicative stress conditions and in combination with previous results ([@bib3]) our data indicate that at least two different kinases are involved in controlling H3T45 phosphorylation, with Cdc7/Dbf4 operating during an unperturbed cell cycle and Pkc1 operating under replicative stress conditions where it also coordinates H3K56 acetylation.

In cells subjected to replicative stress it is important to delay chromatin re-assembly until the DNA damage has been resolved, and one way to do this, would be to delay H3 modifications. It is not clear how this delay is achieved but Pkc1 promotes the re-activation of H3 modifications upon removal of replicative stress. Mechanistically, Pkc1 controls H3K56 acetylation through phosphorylating the Rtt109 acetyltransferase. This modification stabilises Rtt109 and thus safeguards its availability for modifying histone H3 following removal of replicative stress and re-entry into the cell cycle. It is possible that Pkc1 might also directly target other elements of the chromatin modification machinery to coordinate efficient chromatin assembly such as occurs with Cdc7-Dbf4 which can also target CAF-1 (chromatin assembly factor 1) ([@bib15]) as well as H3T45.

Under replicative stress conditions, H3T45 phosphorylation appears to be critically important for coupled H3K56 acetylation, and this phosphorylation event is promoted by Pkc1-mediated H3T45 phosphorylation. This is likely direct as histone H3 is efficiently phosphorylated at this site in vitro. This leads to a model ([Figure 7G](#fig7){ref-type="fig"}) whereby Pkc1 promotes the coordinate modification of these two chromatin modifications and H3T45 phosphorylation is functionally coupled to H3K56 acetylation. It is not clear how this coupling is mediated but one possibility is that H3T45 phosphorylation blocks histone binding to DNA, thus allowing H3K56 to be exposed and hence accessible for acetylation by Rtt109. More complex scenarios are of course possible such as phosphorylated H3T45 acting as binding platform for recruiting a histone mark reader which then coordinates H3K56 acetylation. Indeed, further complexities in the regulatory links between histone H3 modifications and Pkc1-mediated signalling are suggested by the observation that Pkc1 levels appear to be reduced in *H3(T45A)* mutant strains (data not shown). Future studies will be required to distinguish between and dissect out the underlying molecular mechanisms. One outcome of perturbed Pkc1 activity and its downstream molecular events following HU treatment is likely to be defective chromatin assembly and preliminary evidence suggest that this might be the case (data not shown). Our data show a consistent sensitivity of *pkc1, rtt109(T46A)* and *H3(T45A)* mutants to HU treatment which complements previous data showing that *H3(K56A)* alleles are also sensitive to HU ([@bib27]) and supports a role in replicative stress. However, the response to other stress inducing conditions such as MMS and 6-AU treatment is less clear. For example, the *H3(T45A)* strain is sensitive to both MMS and 6-AU whereas the *rtt109(T46A)* strain is only sensitive to MMS (data not shown). Thus different elements of the regulatory network we have uncovered may be used to respond to different stress inducers.

Another open question is how Pkc1 is specifically targeted/activated during replicative stress but one potential regulator would the cell cycle-dependent changes of the cell wall and signalling through the cell wall integrity pathway. Alternatively, other upstream pathways might be involved, and one potential link might be through TOR signalling as TORC2 has been shown to phosphorylate and activate Pkc1 ([@bib28]) and TOR signalling has also been linked to H3K56 acetylation ([@bib6]). Whether such a route operates during replicative stress or is employed under different conditions is not clear but re-emphasises the potential widespread importance of connections between Pkc1 and histone H3 modifications we have identified.

Our work may be directly relevant to mammalian systems where PKCδ has been shown to phosphorylate H3T45 under apoptotic conditions ([@bib18]), although others have identified AKT as an additional H3T45 kinase under DNA damage conditions ([@bib23]). It is not clear whether PKC is linked to H3K56 acetylation in mammals but this modification is induced by replicative stress and its deposition is mediated by p300/CBP, the functional homologue of Rtt109 ([@bib10]; [@bib38]). Indeed, atypical protein kinase C zeta has been shown to phosphorylate and control the histone acetylation output of CBP in the context of neuronal differentiation ([@bib40]). Given these links between PKC and CBP/p300 it appears likely that our findings will be directly relevant to human cancer where oncogene-driven replicative stress is an important contributory event ([@bib4]) and therefore warrants further investigation.

Materials and methods {#s4}
=====================

Plasmid construction and mutagenesis {#s4-1}
------------------------------------

For bacterial expression: pET28a+His-Rtt109 and pET3a-Tr-Vps75-Flag was kindly provided by Paul Kaufman ([@bib37]).

For yeast expression; pVD67 (pAS1995; encoding wild-type GFP-Pkc1), pVD61(empty vector) and pVD124 (kinase-dead GFP-Pkc1) were kindly provided by Martha Cyert ([@bib11]). pAS4104 encoding Myc-Rtt109, pAS4105 (myc-Rtt109T46A) and pAS4106 (myc-Rtt109T46D) were made by inserting BamHI-cleaved PCR product generated using the templates pAS4101-4103 and primer pair ADS4723/4724 into pCM188. pAS4101 was generated by amplifying the cDNA sequence of the *RTT109* gene encoding full-length protein from yeast genomic DNA and cloning into pGBKT7 using EcoRI/SalI restriction sites. pAS4102 (encoding Rtt109\[T45A\]) and pAS4103 (encoding Rtt109\[T45D\]) were created by QuikChange mutagenesis (Stratagene) using the primer pairs ADS4727/ADS4728, ADS4729/4730 and pAS4101 as a template. pGal1Vps75-flag was kindly provided by Tom Owen-Hughes.

Protein production, pulldown assay and western blotting {#s4-2}
-------------------------------------------------------

His-tagged fusion proteins were prepared using Ni-NTA agarose beads (Qiagen, UK) according to the manufacturer's protocol and HA epitope-tagged Pkc1p were prepared essentially as described previously ([@bib9]). Recombinant histone H3 was made commercially (Active Motif).

Pulldown assays with immunoprecipitated HA-Pkc1 from DZ2 cells and in vitro translated Rtt109 were carried out as described previously ([@bib30]).

To detect epitope-tagged derivatives by western analysis, anti-HA (Roche) and anti-tubulin TAT-1 (CRUK), H3K56ac (Active motif), H3K9ac (Abcam), H3K18ac (Abcam), H3 (Active motif), myc epitope (Santa Cruz), H3T45-P (Active motif) antibodies and Supersignal west dura substrate (Pierce) were used.

Rabbit polyclonal monospecific antibody against the phosphothreonine at amino acid 46 on yeast Rtt109 (Rtt109 T46-P) was generated from immunizing rabbits with a KLH-conjugated peptide (H-DDKRVPKST(PO~3~H~2~)IKTC-NH2), and then cross-affinity purification of polyclonal antibodies specific to modified Rtt109 T46-P or non-modified pRtt109 was performed (Eurogentec). For immunoblotting analysis we used 1:1000 dilution for both antibodies.

Protein kinase assays {#s4-3}
---------------------

Protein kinase assays were performed as described previously ([@bib9]) using HA epitope-tagged Pkc1p immunoprecipitated form DZ2 cells and recombinant H3 or His-Rtt109/Vps75 protein complex as a substrate.

Mass spectrometry {#s4-4}
-----------------

Proteins were isolated from denaturing polyacrylamide gels and proteolytically digested as described previously ([@bib9]). Digested samples were analysed by LC-MS/MS using an UltiMate^®^ 3000 Rapid Separation LC (RSLC, Dionex Corporation, Sunnyvale, CA) coupled to an Orbitrap Elite (Thermo Fisher Scientific, Waltham, MA) mass spectrometer. Peptide mixtures were separated using a gradient from 92% A (0.1% FA in water) and 8% B (0.1% FA in acetonitrile) to 33% B, in 44 min at 300 nl min^-1^, using a 75 mm x 250 μm i.d. 1.7 μM BEH C18, analytical column (Waters). Peptides were selected for fragmentation automatically by data dependant analysis. Data were analysed as described previously ([@bib9]) but phosphorylated peptide product ion spectra were also manually validated.

Yeast growth and RNA analysis {#s4-5}
-----------------------------

The yeast strains used are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Yeast cells were grown, *GAL1*-promoter-driven constructs induced, and transformations performed, as described previously ([@bib7]). Yeast cultures were treated with 40 nM cercosporamide (Santa Cruz) to inhibit PKC activity, synchronised in G1 phase by treatment with α-factor and in early S phase by hydroxyurea (HU) treatment as described previously ([@bib9]). DNA content analyses were performed using propidium iodide-stained cells as described previously ([@bib8]).

Growth sensitivity tests were performed as described previously ([@bib9]) except that temperature sensitive *pkc* mutant strains were grown at 30°C or 34°C. The experiments were performed in duplicate and were repeated several times.

RNA extraction and real-time reverse transcription-PCR (RT-PCR) analysis were carried out as described previously ([@bib8]) using the following primer pairs: ADS1587/1588 (*HTT2*), ADS4732/4733 (*RTT109*) and ADS3978-ADS3979 (*18S rRNA*). All data were normalized to *18S rRNA* levels in the same cells.

Microarray analysis {#s4-6}
-------------------

Duplicate RNA samples were labelled and hybridised after a single round of amplification to Affymetrix Yeast Genome 2.0 array chips. All the cell strains used in this experiment were grown in the presence of 1M sorbitol at 30ºC, treated with 200 mM HU for 2.5 hr and released from HU block at 34ºC. Samples were obtained from: (1) Wild-type (DK186) and *pkc1-14* (DK1690) mutant strains. The mRNA expression data were collected at three timepoints (wild-type blocked in HU, wild-type and *pkc1-14* released from HU block for 75 min. (2) *rtt109Δ* mutant cells (Y01490) containing vectors expressing wild-type (WT) Rtt109 (DZ5) or Rtt109(T46A) (DZ6). The mRNA expression data were collected at three timepoints (WT blocked in HU, and Rtt109(WT) and Rtt109(T46A) released from HU block for 80 min. (3) Wild-type cells (MSY748) expressing wild-type histone H3 (MSY748) or H3(T45A) (H3-T45A). The mRNA expression data were collected at three timepoints (WT blocked in HU, and both WT and H3(T45A) released from HU block for 80 min). The measurements were then normalised by using robust multi-array average (RMA) approach ([@bib20]). The primary data are deposited in ArrayExpress; accession number E-MTAB-3359.

Limma ([@bib34]) was used to provide log(foldChange), T-statistic and P-values. In all cases, fold changes were calculated relative to the wild-type strain released from HU block. Individual gene expression changes were considered significant if they satisfied the criteria of fold change \>1.2 and P-value \<0.05. The T-statistics, P-values and Fold Changes were used by Piano ([@bib39]) to build aggregate P-values for all of the genes in each GO term, based upon the values of these statistics for each of the probe sets matching to the term. GO terms were then ranked separately by aggregate P-values, within each of the five P-value directional classes (upregulated or downregulated in both conditions), and this ranking provided a consensus score.

To create heatmaps of expression changes of genes within GO terms z-scores were calculated for the set of arrays testing a pair of strains across different conditions and an average z-score for each condition determined. Each paired experiment was treated independently and the z-scores were clustered and depicted in a heatmap using pheatmap (<http://cran.r-project.org/web/packages/pheatmap/index.html>).

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/501100000268Biotechnology and Biological Sciences Research Council BB/H1010858/1 to Andrew D Sharrocks.

-   http://dx.doi.org/10.13039/100004440Wellcome Trust 103857/Z/14/Z to Andrew D Sharrocks.

-   Royal Society Wolfson to Andrew D Sharrocks.

We are grateful to Karren Palmer for technical support, and to staff in the core genomics technologies, mass spectrometry, bioinformatics, and flow cytometry facilities. We also thank Catherine Millar, Alan Whitmarsh, Iain Hagan and members of our laboratories for comments on the manuscript and helpful discussions, and Catherine Millar, Martha Cyert, Paul Kaufman, Tom Owen-Hughes, and Doug Kellog for reagents. This work was supported by the BBSRC, the Wellcome Trust and a Royal Society-Wolfson award to ADS.

Additional information {#s5}
======================

The authors declare that no competing interests exist.

ZD, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

AW, Conception and design, Analysis and interpretation of data, Drafting or revising the article.

SW, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

ADS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.

Additional files {#s6}
================

10.7554/eLife.09886.018

###### Yeast strains used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.09886.018](10.7554/eLife.09886.018)

10.7554/eLife.09886.019

Decision letter

Tyler

Jessica

Reviewing editor

University of Texas MD Anderson Cancer Center

,

United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled \"Protein kinase C coordinates histone H3 phosphorylation and acetylation\" for peer review at *eLife*. Your submission has been favorably evaluated by Jim Kadonaga (Senior editor), and two reviewers, one of whom is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission. The reviewers felt that your work was interesting, important and timely.

Essential revisions:

1\) All MNase analyses have to be removed from the paper.

2\) Show the effect on H3 K56Ac of Pkc inhibition in the *pkc1-14* and *pkc1-21* mutants, to establish whether they are epistatic, given their different effect on the kinetics of H3 K56Ac.

3\) Indicate concentrations of HU and temperatures used for all experiments.

4\) Include H3K56A or R mutants in the epistasis analysis in [Figure 7D](#fig7){ref-type="fig"} to enable a better understanding of the codependence of H3 K56Ac, H3 T64p and Rtt109p.

5\) Make the gene expression data publicly available.

6\) Please show or report result of sensitivities of the *pkc1*, H3T45 and Rtt109T46 alleles to MMS and 6AU.

We have included the full reviews for your benefit below.

*Reviewer \#1:* This is an interesting paper that shows that Pkc1 phosphorylates the HAT Rtt109 to stabilize Rtt109 after release from HU treatment, enabling it to acetylate H3 K56 during S phase. They also show that Pkc1 promotes phosphorylation of H3 T45, which also promotes H3 K56Ac. The findings are novel and important. Some of the westerns are rather ugly but are still convincing. The micrococcal nuclease analyses however are not technically acceptable nor credible, nor consistent with data published for the same mutants in the literature previously. Additionally, they do not add anything to the story and need to be removed, given the effect of lack of H3 K56Ac on chromatin and MNase ladders is well established already.

For future reference this is what is wrong with the MNase ladders (probably irrelevant here, because these all have to be removed from the paper), MNase accessibility analysis requires multiple time points or different MNase concentrations to be shown for each chromatin sample, not just one. The gel percentages and ladders need to be used that will enable 150bp and 300bp fragments to be seen. Also, the same amount of sample has to be digested for different samples. This is clearly not the case in these MNase analyses, especially [Figure 2](#fig2){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}. For the MNase digestion in [Figure 1](#fig1){ref-type="fig"}, the wild type sample is totally unconvincing. It is not a MNase ladder -- there are intermediate bands between the nucleosomes and the tri-nucleosome is far brighter than the mono and di bands, but there is no tetra. This does not happen; they never look like this; and the state of overdigestion of the Pkc1 mutant would not be compatible with life! The results of the MNase digestion analysis of H3 K56R is far more extreme than what Steve Jackson published in Nature nearly ten years ago, and this degree of relative lack of chromatin would not support life. [Figure 2](#fig2){ref-type="fig"} MNase also lacks a ladder. The labeling of the size markers on [Figure 5](#fig5){ref-type="fig"} does not correspond to the size markers and appears to be completely arbitrary. Where is the mononucleosome on this analysis? A ladder cannot have di and tri and no mononucleosome.

*Reviewer \#2:* Sharrocks and colleagues present a number of interesting experiments that implicate the yeast PKC kinase in chromatin assembly regulation. Yeast growth phenotypes are applied to implicate pkc1 alleles in HU resistance and H3K56 acetylation as well as to study H3 and Rtt109 PKC phosphorylation site mutant alleles. Co-IP and in vitro and in vivo phosphorylation assays suggest a network of phosphorylation whereby PKC may directly phosphorylate H3 on T45 and Rtt109 on T46. The emergent model is attractive because there appears to be a two-pronged PKC-mediated regulatory pathway, whereby direct PKC phosphorylation of H3T45 promotes acetylation of H3K56 whilst concomitant phosphorylation of the H3K56 acetylase Rtt109 on T46 also promotes H3K56 acetylation. The model appears to have been tested adequately to sustain the claims, including epistasis experiments using colony formation and gene expression as a read-outs.

The MNase experiments are scattered over three figures (1C, 2C, 6E), assessing MNase patterns in wild type, *pkc1-14* (1C) H3K56R (2C) and a H3T45A mutant +/- PKC1 expression (6E). It is not clear whether as such these add substantially to the manuscript. Technically a full titration/time course of MNase for each strain/condition would be more informative. Furthermore, as different strain backgrounds are compared (1C = W303, 2C = Rothstein 1983 = W303, 6E = FY406), at different temperatures (30ºC? and 34ºC), the only result is that the chromatin structure is MNase hypersensitive and therefore \'messed up\'. The assays displayed do not have the resolution to indicate in what way or to what extent the chromatin is messed up. Darieva et al. again do not systematically indicate at what temperature the control strain was grown. I feel that one dedicated accessibility figure describing a logical set, rather than the present chronological-discovery-set across three figures would render the manuscript stronger on this front. For instance, comparing WT, H3T45A and H3T45D combined with *pkc* mutants at 34ºC. A further set of possibilities would include the H3K56A, and R mutations. Yet another, would employ the rtt109 null and Rtt109A and Rtt109D alleles. Leaving MNase experiments out altogether is also an option, however.

10.7554/eLife.09886.020

Author response

*1) All MNase analyses have to be removed from the paper.*

We have now removed all of this data and amended the text appropriately. We would like to emphasise however that the MNase digests were carried out on chromatin isolated from cells released from HU treatment (perhaps not made clear in the paper). Under these conditions, it might be expected that chromatin would not be fully assembled correctly as many cells are still in S phase. In the case of defective Pkc signalling (and its downstream molecular events) we consistently saw changes relative to WT cells, and the increased MNase susceptibility would likely be resolved after longer release times from HU block (and hence compatible with cell survival). We do however appreciate that there are technical shortcomings with the current data (although we did use equal amounts of chromatin for each digestion) and agree that the data are not central to the paper and merit further investigation to pin down the precise defects involved. We have now mentioned this possibility in the Discussion as an area to investigate more fully in the future.

*2) Show the effect on H3 K56Ac of Pkc inhibition in the* pkc1-14 *and* pkc1-21 *mutants, to establish whether they are epistatic, given their different effect on the kinetics of H3 K56Ac.*

We have done this experiment and included it in the revised version (see [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"}). This clearly demonstrates that the Pkc1 inhibitor (cercosporamide) inhibits H3K56Ac in wild-type cells but does not further affect the residual levels of H3K56Ac in cells depleted of Pkc1 activity in the *pkc1-14* temperature sensitive mutant strain. The difference in effects is likely caused by incomplete inhibition of Pkc1 activity by the inhibitor, leading to less severe effects on H3K56Ac levels (now commented on in the text).

*3) Indicate concentrations of HU and temperatures used for all experiments.*

This information has now been added to the figure legends where currently missing. We have also clarified the conditions of the microarray experiments in the Materials and methods and figures (which were not labelled properly in the previous version of the paper) and legend.

4\) Include H3K56A or R mutants in the epistasis analysis in [Figure 7D](#fig7){ref-type="fig"} to enable a better understanding of the codependence of H3 K56Ac, H3 T64p and Rtt109p.

These additional experiments has now been done (new [Figure 7--figure supplement 2](#fig7s2){ref-type="fig"}) and demonstrate that Rtt109(T46D) is unable to rescue the defects in the H3K56R mutant strain. This lends further support for the model that Rtt109 functions primarily through H3K56Ac in this context.

*5) Make the gene expression data publicly available.*

This data was already deposited in the ArrayExpress database (mentioned in first version of the manuscript) and will be released to the public upon publication.

*6) Please show or report result of sensitivities of the* pkc1*, H3T45 and Rtt109T46 alleles to MMS and 6AU.*

We have now performed these experiments and there is a complex behaviour which is beyond the scope of this paper to investigate in detail. We have therefore not shown this data in the current paper. However, the data do show that although the phenotypic defects we see for all the mutant alleles investigated in this study under HU-mediated stress conditions, show consistent sensitivity responses, this is not the case in the context of MMS or 6-AU treatment which are known to elicit different molecular defects in yeast cells. We have however included an additional paragraph in the Discussion section to highlight this point:

**"**Our data show a consistent sensitivity of *pkc1, rtt109(T46A)* and *H3(T45A)* mutants to HU treatment which complements previous data showing that *H3(K56A)* alleles are also sensitive to HU (Matsubara et al., 2007) and supports a role in replicative stress. However, the response to other stress inducing conditions such as MMS and 6-AU treatment is less clear. For example, the *H3(T45A)* strain is sensitive to both MMS and 6-AU whereas the *rtt109(T46A)* strain is only sensitive to MMS (data not shown). Thus different elements of the regulatory network we have uncovered may be used to respond to different stress inducers."
